This observation has significant therapeutic implications since AT2R agonists, which may be beneficial in some conditions such as stroke (15, 16), aneurysm formation (17, 18) and myocardial fibrosis (19), would not be appropriate in patients with elastin insufficiency. This evidence concerns the gene ELN and aneurysm.